Posted on November 21, 2017
DCEG investigators played leading roles in the 2017 NCI Cohort Consortium Annual Meeting, which took place on November 13th and 14th at the NCI Shady Grove campus. The meeting, co-sponsored by DCEG and the Division of Cancer Control and Population Sciences (DCCPS), brought together an international group of scientists to share updates and discuss future directions of the Consortium. Taken together, members of the large-scale consortium are responsible for more than 50 high-quality cohorts that include over seven million people.
Day one began with working group meetings for individual consortia. Nicolas Wentzensen, M.D., Ph.D., co-led the Ovarian Cancer Cohort Consortium meeting.
DCEG Director Stephen Chanock, M.D., and Debbie Winn, Ph.D., Deputy Director of DCCPS, delivered opening remarks and provided an overview of NIH activities since the last meeting.
On day two, Mitchell Gail, M.D., Ph.D., presented “Cohort Consortium Data for the Development, Validation and Estimation of the Utility of Risk Models for Disease Prevention,” and Katherine McGlynn, Ph.D., M.P.H., reported on the Liver Cancer Pooling Project.
A second round of working group meetings were co-led by DCEG investigators including Michael Cook, Ph.D., on Prostate Cancer, Aimée Kreimer, Ph.D., on Markers of HPV Infection and Risk of Head and Neck Cancer, Jonathan Hofmann, Ph.D., M.P.H., on Lymphoid Malignancies, Steven Moore, Ph.D., M.P.H., and Charles Matthews, Ph.D., on Physical Activity, and Rachael Stolzenberg-Solomon, Ph.D., M.P.H., R.D., and Laufey Amundadottir, Ph.D., on PanScan.